04/17/2024
3:34 PM | Jordan Erica (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
12:17 PM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
03/19/2024
5:43 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:44 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:44 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:45 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:16 AM | Revance Therapeutics (Subject)
Sjuts Dustin S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/18/2024
5:10 AM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
5:13 AM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
4:33 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:44 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:39 AM | Revance Therapeutics (Filer)
| Form 424B5 | |
02/29/2024
3:32 PM | Hollander David (Reporting)
Revance Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/29/2024
3:36 PM | Jordan Erica (Reporting)
Revance Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/28/2024
3:07 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:55 PM | Palo Alto Investors LP (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
2:45 PM | Antara Capital LP (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
8:39 AM | Polar Capital Holdings Plc (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
5:21 PM | Capital World Investors (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024
12:58 PM | FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G | |
02/02/2024
3:46 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:48 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:45 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
10:10 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
10:11 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
7:01 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
3:50 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:32 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
3:22 PM | Revance Therapeutics (Filer)
| Form S-3ASR | |
09/19/2023
8:01 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
4:37 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
3:21 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
4:43 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023
8:12 AM | Revance Therapeutics (Subject)
Teoxane SA (Filed by)
| Form SC 13D | |
08/14/2023
7:02 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:40 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023
8:11 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The “Perfect Storm” for Gold (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
07/05/2023
8:11 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:11 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
1:29 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
1:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
7:30 PM | Kolaja Carey OConnor (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
7:09 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:09 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:07 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:08 PM | Revance Therapeutics (Subject)
Sjuts Dustin S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
5:06 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:34 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
4:14 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2023
7:29 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:29 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:29 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:29 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
7:25 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
3:18 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
3:16 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
3:17 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
3:18 PM | Revance Therapeutics (Subject)
Sjuts Dustin S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023
3:34 PM | Revance Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023
4:13 PM | Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:14 PM | Coric Vlad (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:14 PM | Revance Therapeutics (Issuer)
Russell Angus C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:14 PM | Kolaja Carey OConnor (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:14 PM | Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:15 PM | Revance Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:15 PM | Gangolli Julian S (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2023
4:41 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
